Amazon is a company founded by American technology millionaire Jeff Bezos that offers us everything you can buy. Now they are trying to revive our youth. In October 2020, several of the world’s most prominent scientists gathered to discuss biotechnology and the fight against aging. They are currently at this point.
Is Jeff Bezos really capable of providing us with anti-aging technology that will keep us young?
Antiaging biotechnology sounds like some kind of wild science fiction, a la Benjamin Button.
But I promise you, it’s much more real than you can imagine. MIT Technology Review reports that in October 2020, Russian billionaire Yuri Milner invited some of the world’s top scientists to his estate to talk about the potential applications of biotechnology in extending human lifespan. First
Each of the experts in the room gave a brief overview of their various experiments with animal rejuvenation. After this conversation, the billionaire founded Altos Labs with the support of investor Jeff Bezos. The company is researching and testing a technology known as biological reprogramming.
Some people think that this method of cell regeneration can be used to regenerate the entire body of an animal and could eventually be applied to humans.
According to a January 19 press release, Bezos invested in the company, which raised $3 billion on its first day. The Financial Times of London estimates that this is the company’s largest investment round.
Altos Laboratories
Altos Labs aims to extend human life in addition to anti-aging for aesthetic reasons. The company is already registered in the USA and the UK. They maintain institutes in San Diego, the Bay Area, Japan, and Cambridge, United Kingdom. They offered astronomical salaries to everyone and recruited and continued to recruit other academic scientists to participate in their research. Scientists who have already joined the group include:
Juan Carlos Izpisua Belmonte is a Spanish biologist who works at the Salk Institute in California.
famous for fusing human and monkey embryos and speculating that he could extend human life by fifty years
Steve Horvath, professor at UCLA
Shinya Yamanaka, winner of the 2012 Nobel Prize for the discovery of reprogramming, will chair Altos’ scientific advisory board. Peter Walter, whose laboratory at the University of California, San Francisco is behind a molecule showing incredible positive effects on memory, has developed a “biological clock” that can accurately predict human aging.
Wolf Reik, a reprogramming expert, recently resigned as director of Britain’s Abraham Institute.
rearrangement
Yamanaka found that the cells could be induced to return to a primitive state that shares characteristics with embryonic stem cells by adding four proteins. We now call these proteins Yamanaka factors.
In 2016, Belmonte’s lab applied these elements to living mice and saw evidence of age reversal. However, it is not infallible; some mice had symptoms of “reverse aging” while others developed malignant tumors.
“Although there are many obstacles to overcome, there is enormous potential,” Yamanaka said.
Curiosity and research
Altos Labs is basically a place where researchers can be bold and curious in their work. They can investigate subjects and ask questions that would normally be prohibited in a publicly sponsored facility.
Making money is not their immediate goal; instead, they want to make discoveries. Naturally, they realize that the results of their anti-aging research could fetch billions of dollars.
Research conducted at Altos Labs is driven by curiosity. I’m good at it and I like doing it,” noted researcher Manuel Serrano of Altos. In this case, we can be bold and explore because the business is private.
The goal is to understand rejuvenation. Even though it’s not the main goal right now, I would say that making money is a concept that exists.”
Jeff Bezos’ investment in Altos Labs represents a significant milestone in the pursuit of anti-aging and biotechnology. With a revolutionary approach that aims to extend human life spans through biological reprogramming, the company represents a bold venture into what was once considered the realm of science fiction.
The establishment of Altos Labs, backed by a $3 billion investment and led by some of the world’s leading scientists, underscores the potential of this innovative research. By exploring the possibilities of cellular regeneration and the reversal of aging, the company is pushing the boundaries of current scientific understanding. At the forefront of this effort are luminaries such as Juan Carlos Izpisua Belmonte, Steve Horvath, and Shinya Yamanaka, who bring their expertise and pioneering research to the project.
Although the technology is still in its early stages and faces many challenges, including potential risks such as the development of tumors, the enthusiasm and curiosity that drives research at Altos Labs is promising. The focus is on discovery and exploration rather than immediate financial gain, reflecting a commitment to advancing knowledge and achieving breakthroughs in the science of rejuvenation.
In short, Altos Labs represents a fascinating intersection of cutting-edge science and ambitious goals. As the company continues its research, it has the potential to change our understanding of aging and longevity. The journey is likely to be complex and fraught with obstacles, but the quest to extend human life and improve health remains a compelling and transformative aspiration.